EU Approves Lactobacillus Buchneri DSM 32650 As a Feed Additive For All Animals
In a significant development disclosed by the Official Journal of the European Union, the European Commission has issued Regulation (EU) No. 2023/2646 on November 28, 2023. This regulation marks the approval of Lactobacillus brucei DSM 32650, also known as Lentilicactobacillus buchneri, as a feed additive for all animals. The endorsement aligns with Regulation (EC) No 1831/2003 of the European Parliament and of the Council, underscoring the additive's compliance with stringent regulatory standards.
The newly sanctioned feed additive, identified in the annex under the category of "technical additive," falls within the functional group of "silage additive." The specific conditions outlined in the annex provide the authorization framework for this innovative feed additive, with the approval set to remain valid until December 19, 2033. These regulations, set to come into effect on the twentieth day following their promulgation, signal a transformative phase in animal nutrition strategies across Europe.
Lactobacillus brucei DSM 32650, recognized for its role as Lentilicactobacillus buchneri, emerges as a promising addition to the repertoire of feed additives available for all animals. The acknowledgment of its efficacy as a silage additive aligns with the industry's ongoing efforts to enhance nutritional content and preservation methods in animal feed.
The authorization conditions serve as a robust framework, ensuring the responsible and sustainable integration of this feed additive into animal diets. As the European Commission continues to prioritize advancements in agricultural practices, the approval of Lactobacillus brucei DSM 32650 reflects the commitment to fostering innovation in the realm of animal nutrition.
Farmers and industry stakeholders now have access to a new tool in their arsenal, with the potential to enhance the nutritional value and longevity of animal feed. The authorized feed additive's expiration date of December 19, 2033, provides a strategic timeframe for stakeholders to incorporate this innovative solution into their feeding regimens, aligning with evolving standards and expectations in the European agricultural landscape.
The approval of Lactobacillus brucei DSM 32650 stands as a testament to the continuous pursuit of advancements in feed technology, furthering the goal of promoting healthier and more sustainable animal agriculture practices across the European Union.
2026-08-26
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
The European Union (EU) Evaluates Renewal of Authorization for Lactobacillus buchneri DSM 19455 as an Animal Feed Additive
-
IMCD Acquires Dong Yang FT, Entering the Korean Beauty Sector
-
Evonik Cuts 3,200 Jobs: Europe’s Chemical Winter Is Not Over
-
INEOS Closes US Polystrene Plant: 400K Tons of PD in the US Can't Hold On
-
Nouryon Doubles Triethylaluminum Co-catalyst Capacity in China and Makes Several Major Investments
-
Bayer’s Ambitious Gene & Cell Therapy Pipeline Eyes Parkinson’s, Oncology, Rare Diseases
-
Bristol Myers Squibb Launches Mavacamten (“Kopozgo”) in India for Obstructive Hypertrophic Cardiomyopathy
-
India Terminates Anti-Dumping Investigation on Chinese Siloxane Polyoxyalkylene Copolymers
-
$2.43 Billion Deal: Olin Buys Huntsman
-
INEOS Plant Closures Deepen Europe’s Chemical Industry Crisis
Recommend Reading
-
Dow Chemical’s Freeport Plant Fire Contained; No Injuries Reported
-
Three-Phase Plan for 120,000 Tons! “TPU King” Zhuhai Makes Its Move—Covestro’s New Plant Signals Not Just Capacity Expansion but a Full-Scale Upgrade in the Asia-Pacific Market Battle
-
Wanhua Chemical Announces 2026 Investment Plan: RMB 27.3 Billion for Projects Plus RMB 2.22 Billion for Equity Investments
-
BASF Raises API and Excipient Prices
-
Roche Takes Natco to Supreme Court Over Generic Risdiplam Launch in India
-
Premium Global Chemical Sourcing Requests (23-26July, 2026)
-
Premium Global Chemical Sourcing Requests (07-10May, 2026)
-
Microcrystalline Cellulose: Applications in Pharmaceuticals
-
Supply Contraction Meets Weak Consumption—PCs Consolidate in Early May
-
Maintenance Concentration Leads to Cost Decline; April PP Market Experiences Volatile Performance